Search

Your search keyword '"Jordan AS"' showing total 3,145 results

Search Constraints

Start Over You searched for: Author "Jordan AS" Remove constraint Author: "Jordan AS" Journal blood Remove constraint Journal: blood
3,145 results on '"Jordan AS"'

Search Results

2. JAK2/mTOR inhibition fails to prevent acute GVHD despite reduced Th1/Th17 cells: final phase 2 trial results

3. Real-world and clinical trial outcomes in large B-cell lymphoma with axicabtagene ciloleucel across race and ethnicity

4. Clinical and functional spectrum of RAC2-related immunodeficiency

5. Survival in primary hemophagocytic lymphohistiocytosis, 2016 to 2021: etoposide is better than its reputation

7. Genotype, oxidase status, and preceding infection or autoinflammation do not affect allogeneic HCT outcomes for CGD

9. Efficacy and safety of cilta-cel in patients with progressive multiple myeloma after exposure to other BCMA-targeting agents

10. A randomized trial of blood donor iron repletion on red cell quality for transfusion and donor cognition and well-being

12. Impact of CD19 CAR T-cell product type on outcomes in relapsed or refractory aggressive B-NHL

13. Safety and efficacy of tisagenlecleucel in primary CNS lymphoma: a phase 1/2 clinical trial

14. An improved index for diagnosis and mortality prediction in malignancy-associated hemophagocytic lymphohistiocytosis

16. Multiomics analysis of IgM monoclonal gammopathies reveals epigenetic influence on oncogenesis via DNA methylation

17. Rapid tumor DNA analysis of cerebrospinal fluid accelerates treatment of central nervous system lymphoma

18. Factors associated with outcomes after a second CD19-targeted CAR T-cell infusion for refractory B-cell malignancies

23. Human herpesvirus 6 reactivation and disease are infrequent in chimeric antigen receptor T-cell therapy recipients

24. Effective Gene Therapy for Hemophilia a: Novel Re-Dosable Non-Viral Formulation That Provides Stable, and Durable FVIII Expression with Improved Tolerability

25. Biophysical Characterization of the Thermodynamic Basis and Binding Orientation for Factor VIII Membrane Association

26. Factors Associated with Prolonged CRS and Neurotoxicity after Treatment with Axicabtagene Ciloleucel

27. Comparative Efficacy of Ciltacabtagene Autoleucel Versus Elotuzumab, Isatuximab, and Selinexor-Based Regimens in the Treatment of Patients with Relapsed or Refractory Multiple Myeloma with 1-3 Prior Lines of Therapy Using a Matching-Adjusted Indirect Comparison

28. Molecular Classification of Relapsed DLBCL Reveals Novel Biologic Subgroups

29. DEK Regulates B-Cell Proliferative Capacity and Is Associated with Aggressive Disease in Low-Grade B-Cell Lymphoma

30. Reduced Intensity Haploidentical Bone Marrow Transplantation in Adults with Severe Sickle Cell Disease: BMT CTN 1507

31. Monoclonal gammopathy of thrombotic/thrombocytopenic significance

32. Treatment dilemmas in asymptomatic children with primary hemophagocytic lymphohistiocytosis

35. Genetic and mechanistic diversity in pediatric hemophagocytic lymphohistiocytosis

36. Hydroxyurea for secondary stroke prevention in children with sickle cell anemia in Nigeria: a randomized controlled trial

37. Efficacy and safety of cilta-cel in patients with progressive multiple myeloma after exposure to other BCMA-targeting agents

41. A randomized trial of blood donor iron repletion on red cell quality for transfusion and donor cognition and well-being

42. Hematopoietic stem cell transplantation in 29 patients hemizygous for hypomorphic IKBKG/NEMO mutations

44. Efficacy and tolerability of nivolumab after allogeneic transplantation for relapsed Hodgkin lymphoma

46. A Risk-Adapted Study to Assess the Efficacy of Enasidenib and Subsequent Response-Driven Addition of Azacitidine for Newly Diagnosed IDH2-Mutant AML Patients: 3-Year Follow-up

47. Novel Data Analytics Identify Predictors of Quality-of-Life Trajectories in Patients with AML or High-Risk Myeloid Neoplasms

48. Impact of CD19 CAR T-cell product type on outcomes in relapsed or refractory aggressive B-NHL

49. Monoclonal gammopathy of thrombotic/thrombocytopenic significance

50. Cytoskeletal abnormalities and neutrophil dysfunction in WDR1 deficiency

Catalog

Books, media, physical & digital resources